{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:53Z","timestamp":1759400993578},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1978,4,1]],"date-time":"1978-04-01T00:00:00Z","timestamp":260236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[1978,4]]},"DOI":"10.1016\/0041-008x(78)90298-3","type":"journal-article","created":{"date-parts":[[2004,9,25]],"date-time":"2004-09-25T15:07:36Z","timestamp":1096124856000},"page":"191-205","source":"Crossref","is-referenced-by-count":23,"title":["Neurotoxicity of adriamycin (Doxorubicin) perfused through the cerebrospinal fluid spaces of the rhesus monkey"],"prefix":"10.1016","volume":"44","author":[{"given":"Philip C.","family":"Merker","sequence":"first","affiliation":[]},{"given":"Margaret R.","family":"Lewis","sequence":"additional","affiliation":[]},{"given":"Michael D.","family":"Walker","sequence":"additional","affiliation":[]},{"suffix":"Jr.","given":"Edward P.","family":"Richardson","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/0041-008X(78)90298-3_BIB1","series-title":"International Symposium on Adriamycin","first-page":"96","article-title":"Influence of pharmacokinetic variations on the pharmacological properties of Adriamycin","author":"Arena","year":"1972"},{"key":"10.1016\/0041-008X(78)90298-3_BIB2","series-title":"Sixth Int. Congress Pharmacology","article-title":"Use of hypothermia as an adjunct to Adriamycin chemotherapy","author":"Battista","year":"1975"},{"key":"10.1016\/0041-008X(78)90298-3_BIB3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M","article-title":"Adriamycin chemotherapy: Efficacy, safety, and pharmacologic basis of an intermittent single high dosage schedule","volume":"33","author":"Benjamin","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/0041-008X(78)90298-3_BIB4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0041-008X(72)90149-4","article-title":"Chronic toxicity of Adriamycin: A new antineoplastic antibiotic","volume":"21","author":"Bertozzoli","year":"1972","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/0041-008X(78)90298-3_BIB5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01896905","article-title":"Adriamycin: Toxicity data","volume":"26","author":"Bertozzoli","year":"1970","journal-title":"Experientia"},{"key":"10.1016\/0041-008X(78)90298-3_BIB6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Review of Adriamycin: A new anticancer drug with significant clinical activity","volume":"80","author":"Blum","year":"1974","journal-title":"Ann. Int. Med."},{"key":"10.1016\/0041-008X(78)90298-3_BIB7","series-title":"International Symposium on Adriamycin","first-page":"139","article-title":"Clinical trials with Adriamycin: Results of a three-year study","author":"Bonadonna","year":"1972"},{"key":"10.1016\/0041-008X(78)90298-3_BIB8","series-title":"The Experimental Biology of Brain Tumors","first-page":"533","article-title":"Brain tumors and the permeability of adjacent brain","author":"Bourke","year":"1972"},{"key":"10.1016\/0041-008X(78)90298-3_BIB9","first-page":"204","article-title":"Leukoencephalopathy following combined irradiation and intraventricular methotrexate therapy of brain tumors in childhood","volume":"97","author":"Bresnan","year":"1972","journal-title":"Trans. Amer. Neurol. Assoc."},{"key":"10.1016\/0041-008X(78)90298-3_BIB10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1476-5381.1970.tb10358.x","article-title":"Role of the sympathetic nervous systems in daunomycin-induced arrhythmias in the monkey","volume":"39","author":"Burka","year":"1970","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/0041-008X(78)90298-3_BIB11","series-title":"International Symposium on Adriamycin","first-page":"220","article-title":"Preliminary clinical observations on the antitumor effect of Adriamycin","author":"Cardinali","year":"1972"},{"key":"10.1016\/0041-008X(78)90298-3_BIB12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z","article-title":"Adriamycin plus vincristine compared to and combined with cyclophosphamide, Methotrexate, and 5-fluorouracil for advanced breast cancer","volume":"35","author":"Delena","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/0041-008X(78)90298-3_BIB13","first-page":"162","article-title":"Adriamycin-induced myopathies in the Rhesus monkey with emphasis on cardiomyopathy","volume":"33","author":"Denine","year":"1975","journal-title":"Toxicol., Appl. Pharmacol."},{"key":"10.1016\/0041-008X(78)90298-3_BIB14","first-page":"233","article-title":"Experimentazione clinica preliminare con adriamicina per via endoarteriosa continua","volume":"56","author":"DiPietro","year":"1970","journal-title":"Tumori"},{"key":"10.1016\/0041-008X(78)90298-3_BIB15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3171\/jns.1949.6.2.0140","article-title":"Physiological salt solutions for brain surgery: Studies of local pH and pial vessel reactions to buffered and unbuffered isotonic solutions","volume":"6","author":"Elliott","year":"1949","journal-title":"J. Neurosurg."},{"key":"10.1016\/0041-008X(78)90298-3_BIB16","series-title":"International Symposium on Adriamycin","first-page":"153","article-title":"Clinical trials of Adriamycin","author":"Frei","year":"1972"},{"key":"10.1016\/0041-008X(78)90298-3_BIB17","first-page":"753","article-title":"Central nervous system complications after combination treatment with Adriamycin (NSC 123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC 45388)","volume":"58","author":"Gams","year":"1974","journal-title":"Cancer Chemother. Repts."},{"key":"10.1016\/0041-008X(78)90298-3_BIB18","series-title":"International Symposium on Adriamycin","first-page":"226","article-title":"Combined chemotherapy of acute leukemias","author":"Gerhartz","year":"1972"},{"key":"10.1016\/0041-008X(78)90298-3_BIB19","first-page":"107","article-title":"Cardiac status of 40 children receiving Adriamycin (ADR) over 495 mgs\/m2 and animal studies","volume":"15","author":"Gilladoga","year":"1974"},{"key":"10.1016\/0041-008X(78)90298-3_BIB20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1152\/ajplegacy.1962.203.5.775","article-title":"Bulk flow and diffusion in the cerebrospinal fluid system of the goat","volume":"203","author":"Heisey","year":"1962","journal-title":"Amer. J. Physiol."},{"key":"10.1016\/0041-008X(78)90298-3_BIB21","first-page":"31","article-title":"Toxicity of high-dose methotrexate (NSC 740) and citrovorum factor (NSC 3590) in osteogenic sarcoma","volume":"6","author":"Jaffe","year":"1975","journal-title":"Cancer Chemother. Repts."},{"key":"10.1016\/0041-008X(78)90298-3_BIB22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1097-0142(197507)36:1<90::AID-CNCR2820360104>3.0.CO;2-H","article-title":"Combination chemotherapy with Adriamycin and cyclophosphamide for advanced breast cancer","volume":"36","author":"Jones","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/0041-008X(78)90298-3_BIB23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/adc.47.253.344","article-title":"Encephalopathy in acute leukemia associated with methotrexate therapy","volume":"47","author":"Kay","year":"1972","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/0041-008X(78)90298-3_BIB24","first-page":"3","article-title":"Neuropharmacological effects of anticancer drugs perfused through the cerebrospinal fluid system of the Rhesus monkey: Cytosine arabinoside","volume":"15","author":"Merker","year":"1973"},{"key":"10.1016\/0041-008X(78)90298-3_BIB25","first-page":"813","article-title":"Neuropharmacology of Adriamycin (NSC 123127) perfused through the CSF space of monkeys","volume":"34","author":"Merker","year":"1975"},{"key":"10.1016\/0041-008X(78)90298-3_BIB26","first-page":"257","article-title":"Intrathecal methotrexate (NSC 740) therapy for brain tumors in children","volume":"53","author":"Newton","year":"1968","journal-title":"Cancer Chemother. Repts."},{"key":"10.1016\/0041-008X(78)90298-3_BIB27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jama.201.1.93","article-title":"Brain tumor chemotherapy with methotrexate given intrathecally","volume":"201","author":"Norrell","year":"1967","journal-title":"J. Amer. Med. Assoc."},{"key":"10.1016\/0041-008X(78)90298-3_BIB28","first-page":"439","article-title":"Electrolyte and morphologic alterations of myocardium in Adriamycin-treated rabbits","volume":"77","author":"Olson","year":"1974","journal-title":"Amer. J. Path."},{"key":"10.1016\/0041-008X(78)90298-3_BIB29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1152\/ajplegacy.1962.203.5.763","article-title":"Perfusion of the cerebral ventricular system in unanesthetized goats","volume":"203","author":"Pappenheimer","year":"1962","journal-title":"Amer. J. Physiol."},{"key":"10.1016\/0041-008X(78)90298-3_BIB30","series-title":"International Symposium on Adriamycin","first-page":"180","article-title":"Adriamycin and daunomycin in the treatment of vesical and prostatic neoplasias: Preliminary results","author":"Pavone-Macaluso","year":"1972"},{"key":"10.1016\/0041-008X(78)90298-3_BIB31","first-page":"177","article-title":"Some observations on the toxicity of Adriamycin (NSC 123127)","volume":"6","author":"Philips","year":"1975","journal-title":"Cancer Chemother. Rept."},{"key":"10.1016\/0041-008X(78)90298-3_BIB32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM196811072791904","article-title":"Experience with the subcutaneous cerebrospinal fluid reservoir","volume":"279","author":"Ratcheson","year":"1968","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/0041-008X(78)90298-3_BIB33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1212\/WNL.16.7.680","article-title":"Cerebrospinal fluid perfusion for central nervous system neoplasms","volume":"16","author":"Rubin","year":"1966","journal-title":"Neurology"},{"key":"10.1016\/0041-008X(78)90298-3_BIB34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archneur.1973.00490200044005","article-title":"Necrotizing encaphalopathy following intraventricular instillation of methotrexate","volume":"28","author":"Shapiro","year":"1973","journal-title":"Arch. Neurol."},{"key":"10.1016\/0041-008X(78)90298-3_BIB35","first-page":"263","article-title":"Pharmacological and behavioral effects of cerebrospinal fluid (CSF) space perfusion with antimetabolites in the Rhesus monkey","volume":"28","author":"Shepard","year":"1969"},{"key":"10.1016\/0041-008X(78)90298-3_BIB36","first-page":"3771","article-title":"Neuropharmacological effects of methotrexate perfused through the cerebrospinal system of the Rhesus monkey","volume":"36","author":"Shepard","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/0041-008X(78)90298-3_BIB37","author":"Snider","year":"1961"},{"key":"10.1016\/0041-008X(78)90298-3_BIB38","first-page":"73","article-title":"5-Iodo-2\u2032-deoxyuridine (IUDR; NSC 39661) given intraventricularly in the treatment of progressive multifocal leukoencaphalopathy","volume":"57","author":"Tarsey","year":"1973","journal-title":"Cancer Chemother. Repts."},{"key":"10.1016\/0041-008X(78)90298-3_BIB39","first-page":"354","article-title":"Physiologic barriers to pharmacologic efficacy","volume":"3","author":"Walker","year":"1973"},{"key":"10.1016\/0041-008X(78)90298-3_BIB40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archinte.1958.00260140111016","article-title":"Intrathecal amethopterin in neurological manifestations of leukemia","volume":"101","author":"Whiteside","year":"1958","journal-title":"Arch. Int. Med."},{"key":"10.1016\/0041-008X(78)90298-3_BIB41","first-page":"73","article-title":"Adriamycin: an animal model for detection of oncolytic and cardiotoxic activity","volume":"16","author":"Young","year":"1975"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0041008X78902983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0041008X78902983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T06:05:32Z","timestamp":1585893932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0041008X78902983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1978,4]]}},"alternative-id":["0041008X78902983"],"URL":"https:\/\/doi.org\/10.1016\/0041-008x(78)90298-3","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[1978,4]]}}}